Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2026-01-05 @ 1:24 AM
Study NCT ID:
NCT04752332
Status:
TERMINATED
Last Update Posted:
2025-07-15
First Post:
2021-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Neoplasms | View |
Keywords: